Symptoms and Cancer Outcome in Adjuvant Endocrine Therapy for Breast Cancer: Why Are They Associated?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 10, 2013
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Androstadienes (MeSH)
- Antineoplastic Agents, Hormonal (MeSH)
- Aromatase Inhibitors (MeSH)
- Breast Neoplasms (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Mammary Glands, Human (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Outcome Assessment (Health Care) (MeSH)
- Postmenopause (MeSH)
- Tamoxifen (MeSH)
published in
- Journal of Clinical Oncology Journal